Genoverde Biosciences

What Genoverde Biosciences does

Genoverde Biosciences, Inc. is a privately held, Raleigh, North Carolina-based agri-bio technology company operating in the hemp and cannabinoid industry. Founded by Michael Harrington, Ph.D. (CEO), Samuel Hazan, Ph.D., and Todd Michael, Ph.D. (Director of Genomics), the company builds a vertically integrated service platform anchored by plant tissue culture, in which it produces genetically identical, disease-free plantlets on demand, offers long-term cryogenic strain storage and recovery, and runs engineered/mutant strain research programs. Its core technical differentiator is the combination of 'cell wall gene technologies' with bioinformatics, molecular biology, and plant genetics, supported by a curated cultivar library and a patent-pending recovery-and-acclimation method.

The company monetizes through professional services delivered as bespoke engagements rather than standardized SKUs. Plant Tissue Culture (strains on demand, long-term storage and propagation, engineered/mutant strain R&D), Plant Diagnostic Testing (cultivar identity confirmation, somaclonal variation detection, soil and tissue nutrient analysis), and super critical CO2 Extraction Services are sold on a quote basis with multi-year contracts, with pricing available upon request. Customers span growers, breeders, distributors, and regulators in the hemp/cannabinoid value chain, and academic collaborators serve as both credibility anchors and co-development channels.

GenoVerde operates three facilities in the Research Triangle and eastern North Carolina: a research laboratory on Shaw University's downtown Raleigh campus, a production greenhouse at NC State University, and farmland for plantlet-to-flower testing. Capital formation to date has come primarily from non-dilutive sources, including National Science Foundation awards in 2016 and 2018 totaling approximately $1.18M; no institutional venture or strategic investor is disclosed. The company's stated ambition is to position the Southern US as the agri-bio tech leader in the cannabinoid industry.

Name

Genoverde Biosciences

Legal name

Genoverde Biosciences, Inc.

Website

https://genoverde.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Genoverde Biosciences is a Raleigh-based agri-bio tech company that uses plant tissue culture, cell-wall gene technology, and a curated cultivar library to produce disease-free, genetically identical hemp and cannabinoid plantlets, plus diagnostic testing and CO2 extraction services, for growers, breeders, and distributors.

Ownership category

akta.pro rank

Product category

Agricultural Biotechnology Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Agricultural Services (700)

akta.pro primary industry

Transformation & Tissue Culture Platforms (Plant regeneration, delivery systems) (AFABALAH)

akta.pro secondary industries

Trait Discovery & Functional Genomics (Target ID/Validation) (AFABALAC), Digital Breeding & Bioinformatics Software (Breeding informatics, decision tools) (AFABALAL)

Keywords

• Plant tissue culture
• Plant diagnostic testing
• Hemp cultivar genetics
• Cryogenic strain storage
• CO2 extraction services

Headquarters

HQ city

Raleigh

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Plant Tissue Culture production and strain storage services: Revenue from bespoke plantlet production runs, long-term cryogenic strain storage, recovery/acclimation of stored strains, and engineered/mutant strain R&D collaborations for the cannabinoid industry. Sold as custom programs rather than standardized SKUs.
2. Plant diagnostic and soil/tissue testing services: Fee-based diagnostic testing (DNA/genetic identity, somaclonal variation, soil and plant tissue nutrient analysis) provided to growers, breeders, distributors, and regulators before, during, and after each season.
3. Cannabinoid extraction services: Super critical CO2 extraction services for cannabinoid processors, sold as bespoke programs with pricing available on request.

Pricing tiers

Go-to-market motion2 records

Core offering

Genoverde Biosciences provides bespoke plant tissue culture and plant diagnostic testing services to the hemp/cannabinoid industry, producing hundreds of genetically identical, disease-free plantlets on demand (Strains on Demand) and offering long-term cryogenic strain storage, patent-pending recovery and acclimation, engineered/mutant strain R&D, DNA-based cultivar identity and somaclonal variation testing, soil/plant tissue nutrient diagnostics, and super critical CO2 extraction services for downstream processors.

Product overview

Genoverde Biosciences offers a portfolio of agri-bio tech services for the hemp/cannabinoid industry rather than a single unified software product. The core offering is Plant Tissue Culture (genetically identical, disease-free plantlet production on demand, long-term genetic storage at sub-80 degree temperatures, and engineered/mutant strain R&D), supported by Plant Diagnostic Testing (soil and plant tissue nutrient analysis, cultivar identity confirmation, and somaclonal variation detection powered by bioinformatics and molecular biology). These services leverage the underlying Cultivar Library as a shared knowledge asset and are complemented by Extraction Services using a super critical CO2 extraction facility for downstream crop processing. Together, the tissue culture, diagnostic, cultivar library, and extraction offerings span the value chain from genetics and plantlet production through harvest processing.

Differentiator

Problem solved

Functional benefit

Products and services

• Plant Tissue Culture Bespoke plant tissue culture service that produces hundreds of genetically identical, disease-free plantlets on demand using patented/patent-pending technology. Includes Strains on Demand micropropagation, long-term cryogenic strain storage, recovery/acclimation of stored strains, and engineered/mutant strain R&D collaborations for growers, breeders, and research partners in the cannabinoid industry.
• Plant Diagnostic Testing Fee-based laboratory testing service providing quick identification of plant and soil health, including soil and plant tissue elemental diagnostics, nutrient analysis, cultivar identity confirmation, and somaclonal variation detection across the hemp/cannabinoid supply chain. Serves growers, breeders, distributors, and regulators before, during, and after each season.
• Extraction Services Bespoke crop processing service using GenoVerde's super critical CO2 extraction facility to deliver a cleaner, higher-purity end product for cannabinoid processors, with pricing provided upon request.

Quantifiable outcome

• Hundreds of genetically identical, disease-free plantlets produced per production run on demand
• +1 more outcomes

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Partnerships

Four partnerships are on record, tiered flagship and minor.

• Shaw UniversityflagshipStrategic or Co-development PartnerShaw University hosts GenoVerde's research lab on its downtown Raleigh campus. As a Historically Black University, Shaw provides GenoVerde with academic credibility and access to researchers in the Research Triangle. GenoVerde leverages the partnership to advance IP development in cannabinoid tissue culture protocols, micropropagation automation, and full-scale production testing.
• North Carolina State University (NC State)flagshipStrategic or Co-development PartnerNC State University hosts GenoVerde's production greenhouse and is co-located with Sam Cook Jr. (an advisor with 30 years of forestry experience at USDA and International Paper who serves as Executive Director of Forestry Assets at NC State University). The partnership supports full-scale production testing from plantlet to flower and provides access to world-class agricultural researchers.
• Kennedy / Shore Entrepreneurship Center, Kennesaw State UniversityminorOthersAdvisory affiliation: Dr. Birton Cowden (Ph.D., MBA, MS) serves as a GenoVerde advisor in his capacity as Research Director at the KSU Robin and Doug Shore Entrepreneurship Center (Kennesaw State University), bringing expertise in international business and strategic management.
• Technical UpgradeOthers

Scale indicators5 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Front Range Biosciences: Front Range Biosciences operates a plant tissue culture platform producing disease-free, true-to-type cannabis and hemp plantlets at commercial scale. It is the closest direct competitor to GenoVerde, addressing the same growers and breeders with the same propagation technology.
• Segra International: Segra International provides cannabis tissue culture micropropagation, genetic storage, and plantlet production services to licensed producers globally. It competes head-to-head with GenoVerde for the same B2B grower and breeder accounts.
• Phylos Bioscience: Phylos is a cannabis genetics company using molecular breeding and tissue culture to produce certified, disease-free cultivars. It overlaps GenoVerde on the genetics, tissue culture, and cultivar-identity confirmation stack.
• Dark Heart Industries: Dark Heart Industries operates cannabis tissue-culture nurseries producing disease-free clones for cultivators. Its tissue-culture production model and target customer (commercial cannabis growers) directly parallel GenoVerde's core offering.

Emerging players

• Medicinal Genomics: Medicinal Genomics provides DNA-based pathogen and genetic identity testing for cannabis and hemp cultivators. Its diagnostic testing capability overlaps GenoVerde's Plant Diagnostic Testing service line.
• Steep Hill: Steep Hill is a cannabis testing and analytics laboratory serving growers, distributors, and regulators. It is adjacent to GenoVerde's diagnostic testing service and shares the same regulated-hemp customer base.
• SC Labs: SC Labs provides cannabis and hemp analytical testing, including genetic identity and potency testing. It overlaps GenoVerde's DNA-based cultivar identity and soil/tissue nutrient testing offerings.

Others

• Agrivida: Agrivida develops engineered cell wall technologies for animal nutrition and biofuel feedstocks. It is thematically adjacent to GenoVerde's stated cell wall gene technology platform for lignocellulosic energy crops.
• ZeaKal: ZeaKal develops plant traits improving photosynthesis, oil composition, and carbon capture in crops. Its cell wall and crop improvement platform is thematically related to GenoVerde's cell wall gene technology work.

Broad incumbents

• Arcadia Biosciences: Arcadia Biosciences is an established agricultural biotechnology company developing crop quality and yield traits across multiple crops. It represents a broader incumbent in the plant genetics/cell wall biotech category GenoVerde aspires to.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/klenrgy-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genoverde Biosciences